CD69 and cancer: From the top hits exclusively identified in the chronic stimulation screen (Figure 4A), multiple genes have been reported previously, either with potential for cancer immunotherapy (Regnase-1,102Cblb,159 and Ccnc92) or associated with exhaustion (Cd69)160 or terminal differentiation (Zeb2).158